Metadoxine Approval Status
- FDA approved: No
- Generic name: metadoxine
- Company: Alcobra Ltd.
- Treatment for: ADHD
Metadoxine is an ion-pair salt of pyridoxine (vitamin B6) in development for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD).
Development Status and FDA Approval Process for metadoxine
|Jan 9, 2017||Alcobra Provides Update on Recent FDA Meeting and Path Forward for MDX Clinical Development Program|
|Feb 7, 2014||Alcobra Announces IND Submission for Extended Release Metadoxine to Treat Adults With ADHD|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.